Moelis & Company
US ˙ NYSE ˙ US60786M1053

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Yvonne Greenstreet. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Yvonne Greenstreet ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:ALNY / Alnylam Pharmaceuticals, Inc. Chief Executive Officer, Director 95.695
US:PCRX / Pacira BioSciences, Inc. Director 13.247
US:MC / Moelis & Company Director 1.059
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Yvonne Greenstreet. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider MC / Moelis & Company - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in MC / Moelis & Company. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

MC / Moelis & Company Insider Trades
Vendite di insider MC / Moelis & Company - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in MC / Moelis & Company. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

MC / Moelis & Company Insider Trades
Acquisti di insider PCRX / Pacira BioSciences, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in MC / Moelis & Company. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

PCRX / Pacira BioSciences, Inc. Insider Trades
Vendite di insider PCRX / Pacira BioSciences, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in MC / Moelis & Company. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

PCRX / Pacira BioSciences, Inc. Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Yvonne Greenstreet come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -265 95.695 -0,28 325,67 -86.303 31.164.991
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -345 95.960 -0,36 324,88 -112.084 31.175.485
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -973 96.305 -1,00 323,84 -315.096 31.187.411
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -444 97.278 -0,45 323,01 -143.416 31.421.767
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -368 97.722 -0,38 321,82 -118.430 31.448.894
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -274 98.090 -0,28 320,81 -87.902 31.468.253
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -129 98.364 -0,13 320,01 -41.281 31.477.464
2026-03-06 2026-03-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -135 98.493 -0,14 319,03 -43.069 31.422.222
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -160 98.628 -0,16 332,64 -53.222 32.807.618
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -399 98.788 -0,40 331,93 -132.440 32.790.701
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -346 99.187 -0,35 330,85 -114.474 32.816.019
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -722 99.533 -0,72 329,71 -238.051 32.817.025
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -424 100.255 -0,42 328,71 -139.373 32.954.821
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.399 100.679 -1,37 327,67 -458.410 32.989.488
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.669 102.078 -1,61 326,81 -545.446 33.360.111
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.098 103.747 -1,05 325,63 -357.542 33.783.136
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -382 104.845 -0,36 324,65 -124.016 34.037.929
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 105.227 -0,19 323,62 -64.724 34.053.562
2026-03-04 2026-03-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 13.844 105.427 15,12
2026-03-02 2026-02-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.921 91.583 6,91
2026-02-17 2026-02-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -6.958 85.662 -7,51 310,08 -2.157.542 26.562.141
2026-02-17 2026-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 14.209 92.620 18,12
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -94 78.411 -0,12 377,82 -35.515 29.625.244
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -118 78.505 -0,15 375,65 -44.327 29.490.403
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -88 78.623 -0,11 374,44 -32.951 29.439.596
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -21 78.711 -0,03 372,46 -7.822 29.316.699
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -118 78.732 -0,15 370,87 -43.763 29.199.337
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -253 78.850 -0,32 369,48 -93.478 29.133.498
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -584 79.103 -0,73 368,62 -215.274 29.158.948
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -261 79.687 -0,33 367,40 -95.891 29.277.004
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -316 79.948 -0,39 366,41 -115.786 29.293.747
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.395 80.264 -1,71 365,56 -509.956 29.341.308
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.259 81.659 -1,52 364,83 -459.321 29.791.653
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -301 82.918 -0,36 363,55 -109.429 30.144.839
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -464 83.219 -0,55 362,38 -168.144 30.156.901
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -624 83.683 -0,74 361,45 -225.545 30.247.220
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -980 84.307 -1,15 360,22 -353.016 30.369.068
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -537 85.287 -0,63 359,14 -192.858 30.629.973
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -778 85.824 -0,90 358,18 -278.664 30.740.440
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -607 86.602 -0,70 357,17 -216.802 30.931.636
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -263 87.209 -0,30 356,09 -93.652 31.054.253
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -269 87.472 -0,31 355,16 -95.538 31.066.556
2026-01-14 2026-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -247 87.741 -0,28 353,95 -87.426 31.055.927
2026-01-14 2026-01-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 19.003 87.988 27,55
2025-12-01 2025-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.121 68.985 -1,60 445,12 -498.980 30.706.603
2025-12-01 2025-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 659 70.106 0,95 151,59 99.898 10.627.369
2025-12-01 2025-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 847 69.447 1,23 118,05 99.988 8.198.218
2025-12-01 2025-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.352 68.600 3,55 85,00 199.920 5.831.000
2025-12-01 2025-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 839 66.248 1,28 119,13 99.950 7.892.124
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -261 65.409 -0,40 456,03 -119.024 29.828.466
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -195 65.670 -0,30 454,69 -88.665 29.859.492
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -881 65.865 -1,32 453,99 -399.965 29.902.051
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.599 66.746 -2,34 452,85 -724.107 30.225.926
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.702 68.345 -2,43 451,94 -769.202 30.887.839
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.218 70.047 -3,07 450,69 -999.630 31.569.482
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.477 72.265 -2,00 450,02 -664.680 32.520.695
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.013 73.742 -1,36 448,76 -454.594 33.092.460
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -654 74.755 -0,87 447,73 -292.815 33.470.056
2025-11-14 2025-11-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10.000 75.409 15,29 119,13 1.191.300 8.983.474
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -430 65.409 -0,65 458,42 -197.121 29.984.794
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -604 65.839 -0,91 457,71 -276.457 30.135.169
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.420 66.443 -3,51 456,64 -1.105.069 30.340.532
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.406 68.863 -4,71 455,56 -1.551.637 31.371.228
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.960 72.269 -2,64 454,84 -891.486 32.870.832
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.069 74.229 -1,42 453,52 -484.813 33.664.336
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.210 75.298 -1,58 452,43 -547.440 34.067.074
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.255 76.508 -1,61 451,16 -566.206 34.517.349
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -453 77.763 -0,58 450,17 -203.927 35.006.570
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.132 78.216 -2,65 449,15 -957.588 35.130.716
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -711 80.348 -0,88 448,07 -318.578 36.001.528
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.000 81.059 22,71 119,13 1.786.950 9.656.559
2025-11-14 2025-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 650 66.059 0,99 42,22 27.443 2.789.011
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -9 65.409 -0,01 457,64 -4.119 29.933.775
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -446 65.418 -0,68 457,43 -204.014 29.924.156
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -221 65.864 -0,33 455,82 -100.736 30.022.128
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -741 66.085 -1,11 454,84 -337.036 30.058.101
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -999 66.826 -1,47 453,77 -453.316 30.323.634
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.029 67.825 -2,90 452,69 -918.508 30.703.699
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.010 69.854 -1,43 451,86 -456.379 31.564.228
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.642 70.864 -2,26 450,81 -740.230 31.946.200
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -758 72.506 -1,03 449,79 -340.941 32.612.474
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -548 73.264 -0,74 448,77 -245.926 32.878.685
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -171 73.812 -0,23 447,92 -76.594 33.061.871
2025-10-03 2025-10-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -350 73.983 -0,47 446,53 -156.286 33.035.629
2025-10-03 2025-10-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 14.252 74.333 23,72
2025-10-03 2025-10-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3.860 60.081 6,87
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -60 56.221 -0,11 455,82 -27.349 25.626.656
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.204 56.281 -2,09 454,84 -547.627 25.598.850
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.716 57.485 -4,51 454,04 -1.233.173 26.100.489
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.646 60.201 -2,66 452,96 -745.572 27.268.645
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -514 61.847 -0,82 451,99 -232.323 27.954.226
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -195 62.361 -0,31 450,92 -87.929 28.119.822
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -450 62.556 -0,71 449,92 -202.464 28.145.196
2025-08-19 2025-08-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -194 63.006 -0,31 447,98 -86.908 28.225.428
2025-08-19 2025-08-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 14.252 63.200 29,12
2025-06-03 2025-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19.297 48.948 -28,28 306,00 -5.904.882 14.978.088
2025-06-03 2025-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.217 68.245 11,83 118,05 851.967 8.056.322
2025-06-03 2025-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 12.080 61.028 24,68 119,13 1.439.090 7.270.266
2025-06-03 2025-05-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.171 48.948 -11,20 306,00 -1.888.326 14.978.088
2025-06-03 2025-05-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25.469 55.119 -31,60 304,00 -7.742.576 16.756.176
2025-06-03 2025-05-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 19.559 80.588 32,05 118,05 2.308.940 9.513.413
2025-06-03 2025-05-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 12.081 61.029 24,68 119,13 1.439.210 7.270.385
2025-05-19 2025-05-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -8.376 48.948 -14,61
2025-05-06 2025-05-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -41.311 57.324 -41,88
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -4 98.635 0,00 248,36 -993 24.496.989
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -23 98.639 -0,02 247,35 -5.689 24.398.357
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -238 98.662 -0,24 246,18 -58.591 24.288.611
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -580 98.900 -0,58 245,26 -142.251 24.256.214
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -791 99.480 -0,79 244,41 -193.328 24.313.907
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.173 100.271 -1,16 243,36 -285.461 24.401.951
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.068 101.444 -1,04 242,37 -258.851 24.586.982
2025-03-05 2025-03-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 17.965 102.512 21,25
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -214 84.547 -0,25 244,11 -52.240 20.638.768
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -440 84.761 -0,52 243,23 -107.021 20.616.418
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.093 85.201 -1,27 242,44 -264.987 20.656.130
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -461 86.294 -0,53 241,51 -111.336 20.840.864
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -284 86.755 -0,33 240,32 -68.251 20.848.962
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -127 87.039 -0,15 239,18 -30.376 20.817.988
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -123 87.166 -0,14 238,33 -29.315 20.774.273
2025-03-03 2025-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -158 87.289 -0,18 236,51 -37.369 20.644.721
2025-03-03 2025-02-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.921 87.447 7,26
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -25 81.526 -0,03 264,87 -6.622 21.593.792
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -21 81.551 -0,03 263,33 -5.530 21.474.825
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -47 81.572 -0,06 261,45 -12.288 21.326.999
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -38 81.619 -0,05 260,57 -9.902 21.267.463
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -21 81.657 -0,03 259,72 -5.454 21.207.956
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -59 81.678 -0,07 258,07 -15.226 21.078.641
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -47 81.737 -0,06 257,51 -12.103 21.048.095
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -98 81.784 -0,12 256,29 -25.116 20.960.421
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -85 81.882 -0,10 255,56 -21.723 20.925.764
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -201 81.967 -0,24 254,35 -51.124 20.848.306
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -300 82.168 -0,36 253,37 -76.011 20.818.906
2025-02-18 2025-02-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -271 82.468 -0,33 252,50 -68.428 20.823.170
2025-02-18 2025-02-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3.859 82.739 4,89
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -300 78.880 -0,38 252,27 -75.681 19.899.058
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.933 79.180 -3,57 251,42 -737.415 19.907.436
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.131 82.113 -1,36 250,68 -283.519 20.584.087
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -762 83.244 -0,91 249,60 -190.195 20.777.702
2024-11-27 2024-11-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -93 84.006 -0,11 247,77 -23.043 20.814.167
2024-11-27 2024-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 10.658 84.099 14,51
2024-08-22 2024-08-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.000 73.441 -16,96 280,00 -4.200.000 20.563.480
2024-08-22 2024-08-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.000 88.441 20,42 85,00 1.275.000 7.517.485
2024-08-02 2024-08-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.148 73.441 -17,10 270,00 -4.089.960 19.829.070
2024-08-02 2024-08-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.148 88.589 20,63 85,00 1.287.580 7.530.065
2024-07-12 2024-07-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.093 73.441 -8,81 261,00 -1.851.273 19.168.101
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -863 80.534 -1,06 235,19 -202.969 18.940.791
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -957 81.397 -1,16 234,66 -224.570 19.100.620
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -595 82.354 -0,72 233,53 -138.950 19.232.130
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.119 82.949 -1,33 232,54 -260.212 19.288.960
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -511 84.068 -0,60 231,59 -118.342 19.469.308
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.572 84.579 -1,82 229,93 -361.450 19.447.249
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.374 86.151 -1,57 229,06 -314.728 19.733.748
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -666 87.525 -0,76 228,30 -152.048 19.981.958
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -177 88.191 -0,20 226,82 -40.147 20.003.483
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -93 88.368 -0,11 225,55 -20.976 19.931.402
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -66 88.461 -0,07 224,17 -14.795 19.830.302
2024-06-26 2024-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -308 88.527 -0,35 221,71 -68.287 19.627.321
2024-06-26 2024-06-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 16.953 88.835 23,58
2024-03-05 2024-03-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 23.754 71.882 49,36
2024-02-29 2024-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -8 48.128 -0,02 158,09 -1.265 7.608.556
2024-02-29 2024-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -84 48.136 -0,17 157,30 -13.213 7.571.793
2024-02-29 2024-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -588 48.220 -1,20 156,38 -91.951 7.540.644
2024-02-29 2024-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -993 48.808 -1,99 155,45 -154.362 7.587.204
2024-02-29 2024-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.259 49.801 -2,47 154,54 -194.566 7.696.247
2024-02-29 2024-02-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.921 51.060 13,12
2024-02-20 2024-02-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -840 45.139 -1,83 149,03 -125.185 6.727.065
2024-02-20 2024-02-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -3.614 45.979 -7,29 148,24 -535.739 6.815.927
2024-02-20 2024-02-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.576 49.593 -4,94 147,50 -379.960 7.314.968
2024-02-20 2024-02-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 16.953 52.169 48,14
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -192 35.216 -0,54 189,31 -36.348 6.666.741
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -17 35.408 -0,05 188,40 -3.203 6.670.867
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -101 35.425 -0,28 187,37 -18.924 6.637.582
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.107 35.526 -3,02 186,39 -206.334 6.621.691
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.869 36.633 -4,85 185,54 -346.774 6.796.887
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -771 38.502 -1,96 184,70 -142.404 7.111.319
2023-08-07 2023-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3.859 39.273 10,90
2023-08-07 2023-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5.082 35.414 16,75
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -533 30.332 -1,73 197,08 -105.044 5.977.831
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -331 30.865 -1,06 195,65 -64.760 6.038.737
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -3.225 31.196 -9,37 194,94 -628.682 6.081.348
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.898 34.421 -7,77 193,93 -562.009 6.675.265
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale -628 37.319 -1,65 193,18 -121.317 7.209.284
2023-04-28 2023-04-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 16.952 37.947 80,74
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -180 20.995 -0,85 210,25 -37.845 4.414.199
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -194 21.175 -0,91 209,85 -40.711 4.443.574
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -195 21.369 -0,90 209,83 -40.917 4.483.857
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5.433 21.564 -20,12 189,76 -1.030.966 4.091.985
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3.859 26.997 16,68
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 4.153 23.138 21,88
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5.083 18.985 36,56
2022-06-08 2022-06-08 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 1.160 13.247 9,60
2022-02-25 2022-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 31.747 31.747
2022-01-04 2021-12-31 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 55.949 55.949
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -122 13.902 -0,87 186,55 -22.759 2.593.418
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1 14.024 -0,01 190,96 -191 2.678.023
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.415 14.025 -14,69 189,13 -456.749 2.652.548
2021-12-23 2021-12-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5.417 16.440 49,14
2021-08-09 2021-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -28.064 0 -100,00
2021-08-09 2021-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X -25.000 0 -100,00
2021-08-09 2021-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -53.064 11.023 -82,80 199,00 -10.559.736 2.193.577
2021-08-09 2021-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 25.000 64.087 63,96 77,10 1.927.500 4.941.108
2021-08-09 2021-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 28.064 39.087 254,59 77,10 2.163.734 3.013.608
2021-06-11 2021-06-09 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 7.626 7.626
2021-06-11 2021-06-09 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 1.066 12.087 9,67
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -85 11.023 -0,77 134,49 -11.432 1.482.483
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.266 11.108 -16,94 131,75 -298.546 1.463.479
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5.083 13.374 61,31
2021-02-26 2021-02-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 28.800 28.800
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -104 8.291 -1,24 155,84 -16.207 1.292.045
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1.841 8.395 -17,99 156,00 -287.196 1.309.620
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8.334 25.000 50,01
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5.416 10.236 112,37
2021-01-13 2021-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -3.125 0 -100,00
2021-01-13 2021-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.125 4.820 -39,33 161,00 -503.125 776.020
2021-01-13 2021-01-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.125 7.945 64,83 42,22 131.938 335.438
2020-07-14 2020-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -46.639 28.064 -62,43
2020-07-14 2020-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -46.639 4.820 -90,63 161,00 -7.508.879 776.020
2020-07-14 2020-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 46.639 51.459 967,61 77,10 3.595.867 3.967.489
2020-07-10 2020-07-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -297 74.703 -0,40
2020-07-10 2020-07-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -10.939 3.125 -77,78
2020-07-10 2020-07-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11.236 4.820 -69,98 161,00 -1.808.996 776.020
2020-07-10 2020-07-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 297 16.056 1,88 77,10 22.899 1.237.918
2020-07-10 2020-07-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10.939 15.759 226,95 42,22 461.845 665.345
2020-06-11 2020-06-09 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 8.027 8.027
2020-06-11 2020-06-09 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 1.260 11.021 12,91
2020-05-07 2020-05-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -50.000 75.000 -40,00
2020-05-07 2020-05-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -50.000 4.820 -91,21 150,00 -7.500.000 723.000
2020-05-07 2020-05-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 50.000 54.820 1.037,34 77,10 3.855.000 4.226.622
2020-05-07 2020-05-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -1.561 14.064 -9,99
2020-05-07 2020-05-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X -6.250 650 -90,58
2020-05-07 2020-05-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.811 4.820 -61,84 140,00 -1.093.540 674.800
2020-05-07 2020-05-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1.561 12.631 14,10 42,22 65.905 533.281
2020-05-07 2020-05-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6.250 11.070 129,67 42,22 263.875 467.375
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -98 4.820 -1,99 107,47 -10.532 518.005
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2.415 4.918 -32,93 104,75 -252.971 515.160
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5.417 7.333 282,72
2020-02-28 2020-02-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 27.623 27.623
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X -5.600 6.900 -44,80
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.892 1.916 -83,77 130,00 -1.285.960 249.080
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5.600 11.808 90,21 42,22 236.432 498.534
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X -6.250 12.500 -33,33
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.250 6.208 -50,17 123,90 -774.375 769.171
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6.250 12.458 100,68 42,22 263.875 525.977
2019-12-26 2019-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8.333 16.666 100,00
2019-12-13 2019-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.208 6.208 -34,07 120,61 -386.917 748.747
2019-12-13 2019-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 7.500 9.416 391,44
2019-11-26 2019-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8.333 8.333
2019-11-22 2019-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -2.154 15.625 -12,12
2019-11-22 2019-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X -6.250 18.750 -25,00
2019-11-22 2019-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.404 1.916 -81,43 105,00 -882.420 201.180
2019-11-22 2019-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6.250 10.320 153,56 42,22 263.875 435.710
2019-11-22 2019-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2.154 4.070 112,42 42,22 90.942 171.835
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 25.000 33,33
2019-08-07 2019-07-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 50 407 14,01
2019-06-07 2019-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 18.750 50,00
2019-06-07 2019-04-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 49 357 15,91
2019-06-06 2019-06-05 4 PCRX Pacira BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 8.437 8.437
2019-06-06 2019-06-05 4 PCRX Pacira BioSciences, Inc.
Common Stock
A - Award 4.134 9.761 73,47
2019-03-01 2019-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 32.500 32.500
2018-11-16 2018-11-14 4 MC Moelis & Co
2018 Elective Restricted Stock Units
A - Award 12 1.059 1,17
2018-11-16 2018-11-14 4 MC Moelis & Co
2018 Annual Restricted Stock Units
A - Award 8 706 1,17
2018-11-16 2018-11-14 4 MC Moelis & Co
2017 Annual Restricted Stock Units
A - Award 13 1.157 1,17
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 12.500 100,00
2018-09-14 2018-09-12 4 MC Moelis & Co
2018 Elective Restricted Stock Units
A - Award 48 1.396 3,57
2018-09-14 2018-09-12 4 MC Moelis & Co
2018 Annual Restricted Stock Units
A - Award 24 698 3,57
2018-09-14 2018-09-12 4 MC Moelis & Co
2017 Annual Restricted Stock Units
A - Award 39 1.144 3,57
2018-09-04 2018-08-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.500 1.916 -56,61 120,00 -300.000 229.920
2018-08-14 2018-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 25.000 25.000
2018-08-14 2018-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.084 4.416 -41,12 90,95 -280.490 401.635
2018-08-14 2018-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 7.500 7.500
2018-08-14 2018-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 38 308 14,07
2018-08-14 2018-04-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 37 270 15,88
2018-07-03 2018-07-02 4 MC Moelis & Co
2018 Elective Restricted Stock Units
A - Award 1.348 1.348
2018-07-03 2018-07-02 4 MC Moelis & Co
2018 Annual Restricted Stock Units
A - Award 674 674
2018-06-15 2018-06-13 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 4.693 4.693
2018-06-15 2018-06-13 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 782 5.627 16,14
2018-05-21 2018-05-17 4 MC Moelis & Co
2017 Elective Restricted Stock Units
A - Award 2 277 0,80
2018-05-21 2018-05-17 4 MC Moelis & Co
2017 Annual Restricted Stock Units
A - Award 9 1.104 0,80
2018-05-21 2018-05-17 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 17 2.079 0,80
2018-03-28 2018-03-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -7.221 17.779 -28,88
2018-03-28 2018-03-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 233 233
2018-03-28 2018-03-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 0 -100,00 141,47 -14.147
2018-03-28 2018-03-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -419 100 -80,73 137,78 -57.730 13.778
2018-03-28 2018-03-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.394 519 -82,18 137,09 -328.193 71.150
2018-03-28 2018-03-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.308 2.913 -59,66 136,00 -585.888 396.168
2018-03-28 2018-03-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.221 7.221 42,22 304.871 304.871
2018-03-09 2018-03-07 4 MC Moelis & Co
2017 Elective Restricted Stock Units
A - Award 20 548 3,78
2018-03-09 2018-03-07 4 MC Moelis & Co
2017 Annual Restricted Stock Units
A - Award 40 1.095 3,79
2018-03-09 2018-03-07 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 75 2.063 3,78
2018-03-05 2018-03-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25.000 25.000
2017-12-21 2017-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 6.250
2017-11-22 2017-11-20 4 MC Moelis & Co
2017 Elective Restricted Stock Units
A - Award 6 792 0,80
2017-11-22 2017-11-20 4 MC Moelis & Co
2017 Annual Restricted Stock Units
A - Award 8 1.055 0,81
2017-11-22 2017-11-20 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 16 1.987 0,81
2017-08-21 2017-08-17 4 MC Moelis & Co
2017 Annual Restricted Stock Units
A - Award 10 1.047 0,96
2017-08-21 2017-08-17 4 MC Moelis & Co
2017 Elective Restricted Stock Units
A - Award 10 1.047 0,96
2017-08-21 2017-08-17 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 19 1.972 0,96
2017-07-10 2017-07-06 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 49 1.953 2,55
2017-07-10 2017-07-06 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 15 597 2,55
2017-07-05 2017-07-01 4 MC Moelis & Co
2017 Annual Restricted Stock Units
A - Award 1.037 1.037
2017-07-05 2017-07-01 4 MC Moelis & Co
2017 Elective Restricted Stock Units
A - Award 1.037 1.037
2017-06-16 2017-06-14 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 2.714 2.714
2017-06-16 2017-06-14 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 1.357 4.845 38,90
2017-05-26 2017-05-24 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 19 1.904 1,02
2017-05-26 2017-05-24 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 6 582 1,02
2017-03-21 2017-03-17 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 18 1.885 0,97
2017-03-21 2017-03-17 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 6 577 0,97
2017-01-09 2017-01-05 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 67 1.867 3,72
2017-01-09 2017-01-05 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 20 571 3,72
2017-01-09 2017-01-05 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 54 1.516 3,72
2016-12-22 2016-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25.000 25.000
2016-12-09 2016-12-07 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 19 1.800 1,07
2016-12-09 2016-12-07 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 6 551 1,07
2016-12-09 2016-12-07 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 15 1.462 1,07
2016-09-21 2016-09-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 125.000 125.000
2016-09-08 2016-09-06 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 22 1.781 1,23
2016-09-08 2016-09-06 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 7 545 1,23
2016-09-08 2016-09-06 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 18 1.446 1,23
2016-07-05 2016-07-01 4 MC Moelis & Co
2016 Annual Restricted Stock Units
A - Award 1.759 1.759
2016-06-17 2016-06-15 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 2.975 2.975
2016-06-17 2016-06-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 1.488 3.488 74,40
2016-06-07 2016-06-03 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 6 538 1,12
2016-06-07 2016-06-03 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 16 1.428 1,13
2016-03-08 2016-03-04 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 21 532 4,20
2016-03-08 2016-03-04 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 57 1.413 4,20
2015-12-10 2015-12-08 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 5 511 1,02
2015-12-10 2015-12-08 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 14 1.356 1,02
2015-09-10 2015-09-08 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 6 506 1,10
2015-09-10 2015-09-08 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 15 1.342 1,10
2015-07-14 2015-07-10 4 MC Moelis & Co
2015 Stub Annual Restricted Stock Units
A - Award 500 500
2015-06-11 2015-06-09 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 9 1.327 0,67
2015-06-05 2015-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 4.000 4.000
2015-06-05 2015-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock
A - Award 2.000 2.000
2015-03-10 2015-03-06 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 8 1.318 0,65
2015-02-23 2015-02-19 4 MC Moelis & Co
Initial Restricted Stock Units
A - Award 1.310 1.310
2014-06-05 2014-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 8.000 8.000
2014-03-06 2014-03-04 4 PCRX Pacira Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 15.000 15.000
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)